GlassScriptPhysician profile
Joseph J Raffa
NPI 1487752663
$2,377.91
in general payments reported to CMS, 2019-2025
10 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3.75 · 2021: $23.94 · 2022: $537 · 2023: $207 · 2024: $462 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,644 · Entertainment: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,644.46 |
| Entertainment | $168.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $801.22 | 2022-2025 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $536.90 | 2021-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $406.14 | 2022-2025 | Clareon, Precision 1, Dailies |
| Glaukos Corporation | $206.44 | 2022-2025 | |
| Optos, INC. | $168.86 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $143.68 | 2023-2024 | |
| Abb Con-Cise Optical Group LLC | $62.46 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Sight Sciences, INC. | $20.96 | 2024 | Tearcare System |
| Johnson & Johnson Vision Care, INC. | $16.15 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $15.10 | 2023 | Lipiflow System Activator (Disposable) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Raffa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.